Company
Every investor coverage indicates participated in a round Austin Health raised.
Companies Austin Health acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Austin Health. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Denteric has begun recruiting early Alzheimer's patients for a Phase I trial of its gingipain-targeting therapy GPV381, with funding from the CUREator+ Dementia program and the Medical Research Future Fund.
Profile of Brisbane AI health startup Maxwell Plus, which recalls a $3.4 million raise led by Main Sequence Ventures and a $1.1 million government grant for Alzheimer's detection work.